By activating the NF‐κB pathway and modulating gut microbiota, EcNT@L demonstrated superior efficacy over conventional antibiotics in combating nano PET‐associated Salmonella infections in murine models. The gene discussed is NFKB1; the disease is Salmonella Infections.